论文部分内容阅读
为进一步提高非手术方法对晚期肺癌的疗效,本文探讨联合应用化疗和LAK(淋巴因子激活的杀伤细胞)/IL—2(白细胞介素—2)晚期肺癌进行序贯治疗,并同单独化疗或单独生物治疗进行对比。观察综合治疗后疗效是否优于单纯治疗。结果显示:综合治疗疗效好于单纯化疗或单纯生物治疗组。
To further improve the efficacy of non-surgical methods for advanced lung cancer, this article discusses the combination of chemotherapy and LAK (lymphokine-activated killer cells) / IL-2 (interleukin-2) advanced lung cancer in sequential therapy, with chemotherapy alone or Biotherapy alone was compared. Observe whether the curative effect after comprehensive treatment is better than simple treatment. The results showed that the efficacy of comprehensive treatment was better than that of chemotherapy alone or biological treatment alone.